Literature DB >> 11490018

Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase.

T Ishizuka1, F Okajima, M Ishiwara, K Iizuka, I Ichimonji, T Kawata, H Tsukagoshi, K Dobashi, T Nakazawa, M Mori.   

Abstract

Although mast cells accumulate within the mucosal epithelial layer of patients with allergic rhinitis and bronchial asthma, the responsible chemotactic factors are undefined. We investigated whether mast cells sensitized with Ag-specific IgE migrate toward the Ag. MC/9 mast cells sensitized with anti-DNP IgE migrated toward DNP-conjugated human serum albumin. This migration was directional, and the degree was stronger than that induced by stem cell factor. IL-3 and stem cell factor-dependent cultured mast cells derived from mouse bone marrow also migrated toward the Ag. Subsequent migration mediated by the Fc(epsilon)RI was significantly inhibited by incubating the cells with Y-27632, a Rho-associated coiled-coil-forming protein kinase inhibitor, or with SB203580, a p38 mitogen-activated protein kinase (MAPK) inhibitor. Both p38 MAPK and MAPK-activated protein kinase (MAPKAPK)2 were activated following Fc(epsilon)RI aggregation, and activation of MAPKAPK2 was almost completely inhibited by 10 microM SB203580. Wortmannin or a low concentration of SB203580 partially inhibited MAPKAPK2, but did not block mast cell migration. In contrast, Y-27632 did not affect the activation of MAPKAPK2. These results indicate that Ag works not only as a stimulant for allergic mediators from IgE-sensitized mast cells, but also as a chemotactic factor for mast cells. Both p38 MAPK activation and Rho-dependent activation of Rho-associated coiled-coil-forming protein kinase may be required for Fc(epsilon)RI-mediated cell migration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11490018     DOI: 10.4049/jimmunol.167.4.2298

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration.

Authors:  In Duk Jung; Hyun-Sil Lee; Hoi Young Lee; Oksoon Hong Choi
Journal:  Cell Signal       Date:  2009-07-24       Impact factor: 4.315

Review 2.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

3.  Molecular mechanisms of spontaneous and directed mast cell motility.

Authors:  Jinmin Lee; Sarah L Veatch; Barbara Baird; David Holowka
Journal:  J Leukoc Biol       Date:  2012-08-02       Impact factor: 4.962

4.  Lactic acid suppresses IgE-mediated mast cell function in vitro and in vivo.

Authors:  Daniel Abebayehu; Andrew J Spence; Heather Caslin; Marcela Taruselli; Tamara T Haque; Kasalina N Kiwanuka; Elizabeth Motunrayo Kolawole; Alena P Chumanevich; Scott A Sell; Carole A Oskeritzian; John Ryan; Sydney Ann Kee
Journal:  Cell Immunol       Date:  2019-04-12       Impact factor: 4.868

5.  Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells.

Authors:  Hye Sun Kuehn; Madeleine Rådinger; Jared M Brown; Khaled Ali; Bart Vanhaesebroeck; Michael A Beaven; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Cell Sci       Date:  2010-06-29       Impact factor: 5.285

6.  Polymer scaffold architecture is a key determinant in mast cell inflammatory and angiogenic responses.

Authors:  Daniel Abebayehu; Andrew J Spence; Michael J McClure; Tamara T Haque; Kevin O Rivera; John J Ryan
Journal:  J Biomed Mater Res A       Date:  2019-01-23       Impact factor: 4.396

Review 7.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

8.  Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.

Authors:  Anuya Paranjape; Oksana Chernushevich; Amina Abdul Qayum; Andrew J Spence; Marcela T Taruselli; Daniel Abebayehu; Brian O Barnstein; Jamie Josephine Avila McLeod; Bianca Baker; Gurjas S Bajaj; Alena P Chumanevich; Carole A Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2016-07-21       Impact factor: 4.962

9.  Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.

Authors:  Andrew S McDaniel; Jayme D Allen; Su-Jung Park; Zahara M Jaffer; Elizabeth G Michels; Sarah J Burgin; Shi Chen; Waylan K Bessler; Clemens Hofmann; David A Ingram; Jonathan Chernoff; D Wade Clapp
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

10.  Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.

Authors:  Sandra E Dillahunt; Jennifer L Sargent; Ryo Suzuki; Richard L Proia; Alasdair Gilfillan; Juan Rivera; Ana Olivera
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.